If people would've (and still can) listened to the webcast (and download the PDF file to follow along), everything you just said would be crystal clear. Steve all but stated that exact same thing- except for the Novartis commitment. One of the analysts questioned Novartis's intent going forward during the Q&A portion of the CC and Steve deferred to "future updates". However, the "new" trial (put together back in February) leads me to believe that Novartis has every intent of continuing to backing them. I keep hoping that we see an 8K released highlighting the fact that a "milestone" benchmark had been reached and the subsequent payment is to be delivered... ;-)
News 
Market Data 
Discover 
